Survival from Sudden Cardiac Arrest More Than Doubles with ZOLL CPR Feedback Technology and Resuscitation Training

  Survival from Sudden Cardiac Arrest More Than Doubles with ZOLL CPR Feedback
  Technology and Resuscitation Training

Business Wire

CHELMSFORD, Mass. -- February 28, 2013

ZOLL Medical Corporation, a manufacturer of medical devices and related
software solutions, announced today that a publication released in the Annals
of Emergency Medicine reported that survival from one of the leading causes of
death in the United States, out-of-hospital cardiac arrest (OHCA), more than
doubled when emergency medical providers utilized ZOLL defibrillators as part
of a focused effort to improve pre-hospital CPR quality and maximize survival
from OHCA in Arizona.

In this study, ZOLL’s defibrillators with CPR feedback technology, including
Real CPR Help^® and CPR Dashboard^™, in combination with scenario-based
training, more than doubled the odds of survival-to-hospital discharge and of
achieving a favorable neurological outcome (adjusted odds ratio of 2.72 and
2.69 respectively).

Using ZOLL’s proprietary technology, rescuers in Mesa, Arizona were able to
significantly increase the depth of the compressions, apply the proper rate of
compressions, limit compression interruptions, shorten their pre-shock pause,
and better deliver ventilations at the recommended rate—all in compliance with
the 2010 American Heart Association (AHA) Guidelines, which place a strong
emphasis on high-quality CPR as a means of improving survival from cardiac

These results are the findings of the four-year endeavor called the Arizona
Pre-hospital CPR Quality Improvement Project that was undertaken by the Mesa
Fire/Medical Department in conjunction with the Save Hearts in Arizona
Registry & Education (SHARE) Program.

“The fact that more than twice as many people returned home to their families
after suffering a cardiac arrest is the outcome that most interests us in
Arizona. The credit really goes to the Mesa Fire/Medical Department. It is
remarkable that 56% of witnessed ventricular fibrillation OHCA victims in the
City of Mesa survived with good functional outcome after they implemented the
training and real-time audiovisual CPR feedback intervention,” said Ben
Bobrow, MD, Medical Director for the Arizona Department of Health Services’
Bureau of EMS and Trauma System and lead author of the study.

“We know that maximizing blood flow to the heart and brain during cardiac
arrest is paramount, but manual CPR without any feedback is often very poor
with lots of interruptions and suboptimal compressions,” Dr. Bobrow said. “We
believe that these results clearly demonstrate how critical it is to measure
CPR quality during cardiac resuscitation.”

“Health care systems need to continuously measure and improve their CPR
quality during resuscitations in order to maximize survival. If EMS systems
were to achieve the Guidelines for CPR quality during cardiac resuscitation,
as they did in Mesa, likely thousands of lives would be saved around the
country each year,” he added.

About Sudden Cardiac Arrest

SCA, an abrupt disruption of the heart’s function, which causes a lack of
blood flow to vital organs, occurs an estimated 380,000 times each year in the
United States and claims more than one million lives globally each year. SCA
is a leading cause of unexpected death in the world and often strikes without
warning. Survival varies widely among communities, yet overall averages around
8% in the U.S. Implementing a system of care including early recognition,
9-1-1 CPR instructions, early defibrillation, and high-quality professional
CPR, along with guideline- based, post-arrest care could save as many as half
of these victims.

About ZOLL Medical Corporation

ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets
medical devices and software solutions that help advance emergency care and
save lives, while increasing clinical and operational efficiencies. With
products for defibrillation and monitoring, circulation and CPR feedback, data
management, fluid resuscitation, and therapeutic temperature management, ZOLL
provides a comprehensive set of technologies that help clinicians, EMS and
fire professionals, and lay rescuers treat victims needing resuscitation and
critical care. For more information, visit

About Asahi Kasei

The Asahi Kasei Group is a diversified group of companies led by holding
company Asahi Kasei Corp., with operations in the chemicals and fibers, homes
and construction materials, electronics, and health care business sectors. Its
health care operations include devices and systems for critical care,
dialysis, therapeutic apheresis, transfusion, and manufacture of
biotherapeutics, as well as pharmaceuticals, diagnostic reagents, and
nutritional products. With more than 25,000 employees around the world, the
Asahi Kasei Group serves customers in more than 100 countries. For more
information, visit

Copyright © 2013 ZOLL Medical Corporation. All rights reserved .CPR Dashboard,
Real CPR Help and ZOLL are registered trademarks of ZOLL Medical Corporation
in the United States and/or other countries. Asahi Kasei is a registered
trademark of Asahi Kasei Corporation. All trademarks are the property of their
respective owners.


Media Contact:
ZOLL Medical Corporation
Diane Egan, +1 978-421-9637
Press spacebar to pause and continue. Press esc to stop.